| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-30 |
| filingDate |
1987-04-28^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59fbd4cc0f10685c35309d5185ec55a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9162b28c8e02e257b6d33393b4c2856
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7b3eb853ff37a4683c0a35328968af3 |
| publicationDate |
1987-11-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0245004-A2 |
| titleOfInvention |
Antihypercholesterolemic compounds |
| abstract |
Novel 3-hydroxy-3-methylaglutaryl-Coenzyme A (HMG-CoA) reductase inhibitors, which are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) and (II)n n and pharmaceutically acceptable salts of the compound (II) ir which Z is hydrogen are disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5075327-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0327165-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0287340-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0287340-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0325817-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0369288-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5073568-A |
| priorityDate |
1986-05-05^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |